Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | News
Search Refinements

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
61-75 of 4468 results
AstraZeneca, Pieris form $2.1bn respiratory drug collaboration
By PBR Staff Writer
AstraZeneca will develop new inhaled respiratory treatments based on Pieris Pharmaceuticals’ Anticalin platform through a collaboration that could generate more than $2bn for the US firm.
Drug Research > Drug Discovery & Development > News
AstraZeneca’s bladder cancer drug imfinzi gets accelerated approval from FDA
The US Food and Drug Administration (FDA) has granted accelerated approval to AstraZeneca’s Imfinzi (durvalumab) for previously treated patients with advanced bladder cancer.
Drug Research > Drug Discovery & Development > News
Shire licenses dry-eye treatment from Parion Sciences
Shire has secured exclusive global rights to develop Parion Sciences' Phase II-stage epithelial sodium channel (ENaC) inhibitor P-321 for the potential treatment of dry eye.
Drug Research > Drug Discovery & Development > News
Bristol-Myers Squibb not to exercise its option to buy F-star Alpha
Bristol-Myers Squibb will not exercise its option to buy F-star Alpha and its lone asset, FS102, an antibody fragment targeting human epidermal growth factor receptor 2 (HER2).
Drug Research > Drug Discovery & Development > News
Takeda, Harrington to advance development of rare disease therapeutics
Takeda Pharmaceutical has entered into a multi-year partnership with Harrington Discovery Institute at University Hospitals in Cleveland, Ohio to advance the development of rare disease rherapeutics.
Drug Research > Drug Discovery & Development > News
Gates Foundation leads $45.5m round for biotechnology firm Arsanis
Clinical-stage biopharmaceutical firm Arsanis has secured $45.5m in a Series D financing round led by the Bill & Melinda Gates Foundation.
Drug Research > Drug Discovery & Development > News
H3 Biomedicine, Foundation Medicine extend precision oncology collaboration
H3 Biomedicine has extended its multi-year collaboration, which was signed in February 2015, with Foundation Medicine to discover and develop precision medicines in oncology.
Drug Research > Drug Discovery & Development > News
Novartis signs collaboration deal with Parvus for diabetes nanomedicine
By PBR Staff Writer
Pharma giant Novartis has acquired the exclusive, worldwide rights for Parvus Therapeutics’ Navacim technology for type 1 diabetes (T1D) treatment.
Drug Research > Drug Discovery & Development > News
Alpine Immune Sciences to merge with Nivalis Therapeutics
Alpine Immune Sciences has agreed to merge with a subsidiary of Nivalis Therapeutics in an all-stock transaction.
Drug Research > Drug Discovery & Development > News
HitGen, Pfizer to build and screen novel DNA-encoded libraries
HitGen has entered into a multi-year research collaboration and license agreement with Pfizer to build and screen novel DNA-encoded libraries (DELs) to potentially discover unique small molecule leads to be used in developing drugs.
Drug Research > Drug Discovery & Development > News
Icon Bioscience submits NDA to FDA for anti-inflammatory drug Dexycu
Icon Bioscience has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its lead pipeline product Dexycu (IBI-10090).
Drug Research > Drug Discovery & Development > News
Lyndra secures $23m funding to develop therapeutic oral delivery platform
Lyndra has secured $23m Series A financing, led by Polaris Partners, with participation from Quark Venture and GF Securities, Yonghua Capital, Healthlink Capital, Suffolk Equity, Partners Healthcare among others.
Drug Research > Drug Discovery & Development > News
BioCryst to explore BCX7353 use in acute HAE attacks
BioCryst Pharmaceuticals revealed its plans to explore a new oral liquid formulation of BCX7353 for the treatment of acute attacks in hereditary angioedema (HAE) patients.
Drug Research > Drug Discovery & Development > News
PureTech Health launches new immuno-oncology programme
PureTech Health has launched a new immuno-oncology programme to develop monoclonal antibodies to target newly discovered immunosuppressive mechanisms in pancreatic cancer and other solid tumours.
Drug Research > Drug Discovery & Development > News
Single dose of live-attenuated Zika vaccine found to protect mice
By PBR Staff Writer
New research has revealed that a single dose of the first live-attenuated Zika vaccine has been found to protect mice against the virus.
Drug Research > Drug Discovery & Development > News
61-75 of 4468 results